Cart
sales@molnova.com
Hylambatin
CAS No. 80890-46-6
Hylambatin( ——— )
Catalog No. M39974 CAS No. 80890-46-6
Hylambatin, a tachykinin, increases both plasma glucose and plasma insulin, whereas the secretion of glucagon was not affected. Hylambatin can be used in diabetes research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
Biological Information
-
Product NameHylambatin
-
NoteResearch use only, not for human use.
-
Brief DescriptionHylambatin, a tachykinin, increases both plasma glucose and plasma insulin, whereas the secretion of glucagon was not affected. Hylambatin can be used in diabetes research.
-
DescriptionHylambatin, a tachykinin, increases both plasma glucose and plasma insulin, whereas the secretion of glucagon was not affected. Hylambatin can be used in diabetes research.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number80890-46-6
-
Formula Weight1439.64
-
Molecular FormulaC63H90N16O19S2
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Güllner HG, et al. Hylambatin, a structurally unique tachykinin: effects on insulin and glucagon secretion. Arch Int Pharmacodyn Ther. 1984 Dec;272(2):304-9.?
molnova catalog
related products
-
Adjudin
Adjudin is a small molecule compound known to possess antispermatogenic function, attenuates microglia activation by suppression of the NF-κB pathway.
-
2B-(S)
2B-(S)
-
15-Lipoxygenase Inhi...
15-Lipoxygenase Inhibitor 1 is a selective inhibitor of 15-lipoxygenase.
